A leading drugmaker ramped up its lobbying in Canada fivefold last year, urging government officials to enact a rule that would give it an effective monopoly on long-acting narcotic painkillers.
Health Canada has decided not to require controlled-release opioid painkillers to be tamper-resistant, saying that measure wouldn’t help Canada’s fastest-growing drug problem, which kills hundreds of people across the country each year.
August 10, 2015 – Anna Mehler Paperny, Global News
David Juurlink sees them daily — old and young, with strokes or pneumonia or broken bones or drug-related overdoses, accidents, constipation.
Their ailments and backgrounds and health conditions run the gamut. And they’re all on high doses of a drug five times more powerful than morphine.
Nineteen thousand, two hundred and thirty-seven tablets.
That’s how many pills an Ontario pharmacy employee was able to steal before being caught in February – by far the biggest oxycodone theft reported from a Canadian hospital or pharmacy since January 2012, according to numbers Health Canada gave Global News.
Canada’s next painkiller crackdown won’t come from Ontario.
Its removal of OxyNEO from the Ontario Drug Benefit successfully sidelined Purdue’s replacement for what was once the most notoriously addictive opioid – OxyContin.
And the province now collects data on all prescriptions filled, not just those the government pays for.
But tackling Canada’s fastest-growing addiction is turning into a game of whack-a-mole: Prescriptions for just about every other potent painkiller are up – way up – in the past two years.
Rebecca Lindell and Anna Mehler Paperny, Global News
This isn’t the first slew of suggestions on how to tackle Canada’s “crisis” in prescription opioid misuse. But many hope it’ll be the last.
A report released Wednesday by the Canadian Centre for Substance Abuse culminates a year-long mind-meld of people representing almost every group in the country with a stake in stopping painkillers from creating addicts, drug dealers and deaths.